Successful use of imiquimod 5% cream in Bowen's disease [2]

Indian Journal of Dermatology, Venereology and Leprology

Volumn 73, Issue 6, 2007, Pages 423-425

  Prabhu, Smitha ^a   Rao, Raghavendra ^a   Sripathi, H ^a   Hameed, Sunaina ^a   Kuduva, Ranjini ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BLEOMYCIN; FLUOROURACIL; IMIQUIMOD;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BOWEN DISEASE; CAUTERIZATION; CLINICAL FEATURE; CRYOTHERAPY; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HUMAN; IMMUNE RESPONSE; LETTER; LOW LEVEL LASER THERAPY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; SKIN BIOPSY; SKIN PIGMENTATION; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; SYMPTOM;

EID: 36448956492     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.37066     Document Type: Letter

References (4)

1. Sauder DN. Immunomodulatory and pharmacologic properties of Imiquimod. J Am Acad Dermatol 2000;43:S6-11.
2. Mackenzie-Wood A, Kossard S, de Launey J, Wilkinson B, Owens ML. Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol 2001;44:462-70.
3. Patel GK, Goodwin R, Chawla M, Leidler P, Price PE, Finlay AY, et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in-situ (Bowen's disease): A randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 2006;54:1025-32.
4. Geisse JK, Rich P, Pandya A, Gross K, Andres K, Ginkel A, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol 2002;47:390-8.